Items Tagged ‘rituxan’

June 8th, 2016

Gazyva® Showed Superior Progression-Free Survival Compared to Rituxan® in Follicular Lymphoma

By

Genentech, announced positive results from the pivotal Phase III GALLIUM study in people with previously untreated follicular lymphoma, the most common type of indolent (slow-growing) non-Hodgkin’s lymphoma (iNHL). The study compared Gazyva® (obinutuzumab) plus chemotherapy (CHOP, CVP or bendamustine) followed by Gazyva alone, head-to-head with Rituxan® (rituximab) plus chemotherapy followed by Rituxan alone. Results from […]

View full entry

Tags: Follicular Lymphoma, GALLIUM study, Gazyva, iNHL, News, nhl, Non-Hodgkin's Lymphoma, non-Hodgkin’s, rituxan, rituximab


December 16th, 2015

Addition of Rituxan Improves Outcomes in Some Acute Lymphoblastic Leukemias

By

The addition of Rituxan (rituximab) to standard chemotherapy-based regimens improves outcomes among patients with B-cell precursor acute lymphoblastic leukemia (BCP-ALL) that is CD20-positive. These results were reported at a plenary session at the 2015 annual meeting of the American Society of Hematology in Orlando, Florida. B-cell precursor acute lymphoblastic leukemia (BCP-ALL) is an aggressive type […]

View full entry

Tags: Acute Lymphoblastic Leukemia, B-cell precursor acute lymphoblastic leukemia, BCP-ALL, CD20-positive, Leukemia, News, riruximab, rituxan


November 18th, 2015

Zydelig® Combined with Treanda and Rituxan Appears Promising in Treatment of Chronic Lymphocytic Leukemia

By

Following the recommendation by an independent Data Monitoring Committee (DMC), Gilead Sciences, Inc today announced that its Phase 3 clinical study evaluating Zydelig® (idelalisib) added to standard therapy in previously-treated chronic lymphocytic leukemia (CLL) patients will be unblinded early. The DMC recommendation is based upon a predefined interim analysis indicating a benefit in patients receiving […]

View full entry

Tags: Chronic Lymphocytic Leukemia, CLL, News, Phase III clinical trial, rituxan, Treanda, zydelig